Clinical Trials Directory

Trials / Unknown

UnknownNCT06057506

Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation

Comparative, Monocentric Study for the Evaluation of the Efficacy of Two Medical Devices on the Treatment of Head Lice Infestation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
136 (estimated)
Sponsor
Perrigo CSCI · Industry
Sex
All
Age
2 Years
Healthy volunteers
Accepted

Summary

Pediculosis capitis or head lice infestation is a human medical condition caused by the infestation of the hair by the parasitic insect Pediculus humanus capitis (human head lice). The most common symptom of infestation is pruritus (itching) on the head which normally intensifies 3 to 4 weeks after the initial infestation. The test items have been developed with the ambition to offer a complete head lice treatment, whilst also offering ultimative convenience in use - making treatment of head lice infestation easy, and effective in few minutes. The main objective of this clinical study is to confirm the efficacy on head lice treatment of two Medical Devices, already in market.

Conditions

Interventions

TypeNameDescription
DEVICEParanix® Shampoowell established medical device for the treatment of head lice infestation (osmolone based)
DEVICEParanix® Lotionwell established medical device for the treatment of head lice infestation (dimethicone based)

Timeline

Start date
2023-08-21
Primary completion
2023-11-01
Completion
2023-11-01
First posted
2023-09-28
Last updated
2023-09-28

Locations

1 site across 1 country: Mauritius

Source: ClinicalTrials.gov record NCT06057506. Inclusion in this directory is not an endorsement.